Original ArticlesSex Differences in Outcome with Bevacizumab Therapy: Analysis of Patients with Advanced-Stage Non-small Cell Lung Cancer Treated with or without Bevacizumab in Combination with Paclitaxel and Carboplatin in the Eastern Cooperative Oncology Group Trial 4599
Under an Elsevier user license
open archive
Key Words:
Non-small cell lung cancer
Sex differences
Bevacizumab
Cited by (0)
Disclosure: Alan B. Sandler serves as a consultant for and has received honoraria and research funding from Genentech. Julie R. Brahmer serves as a consultant for Genentech. Joan Schiller serves as a consultant for and has received research funding from Genentech. Robert Gray has received research funding from Genentech.
This study was coordinated by the Eastern Cooperative Oncology Group (Robert L. Comis, MD, Chair). The contents of the article are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute.
Copyright © 2011 International Association for the Study of Lung Cancer. All rights reserved.